Institutional investors purchased a net $1.1 million shares of GNCA during the quarter ended March 2016. This may signal that the smart money is gaining interest in this company as the 57.00% of shares outstanding that institutional investors hold is actually below the Biotechnology industry average.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
FRANKLIN ADVISERS, INC. Bought 779.4 Thousand shares of Genocea Biosciences Inc
NORTHPOINTE CAPITAL LLC Bought 557.8 Thousand shares of Genocea Biosciences Inc